TALK vs OPRX

For growth investors, Talkspace, Inc.

(TALK) is the stronger pick with 22. 0% revenue growth year-over-year, versus 18. 8% for OptimizeRx Corporation (OPRX). OptimizeRx Corporation (OPRX) offers the better valuation at 24. 0x trailing P/E (6. 9x forward), making it the more compelling value choice. Analysts rate OptimizeRx Corporation (OPRX) a "Buy" — based on 15 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, OptimizeRx Corporation (OPRX) is the cheapest at 24.

0x versus Talkspace, Inc. at 129. 8x. On forward P/E, OptimizeRx Corporation is actually cheaper at 6. 9x.

Over the past 5 years, Talkspace, Inc.

(TALK) delivered a total return of -47. 6%, compared to -86. 5% for OptimizeRx Corporation (OPRX). Over 10 years, the gap is even starker: OPRX returned +105. 4% versus TALK's -48. 6%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Talkspace, Inc.

(TALK) is the lower-risk stock at 0. 86β versus OptimizeRx Corporation's 2. 28β — meaning OPRX is approximately 165% more volatile than TALK relative to the S&P 500.

By revenue growth (latest reported year), Talkspace, Inc.

(TALK) is pulling ahead at 22. 0% versus 18. 8% for OptimizeRx Corporation (OPRX). Over a 3-year CAGR, TALK leads at 24. 2% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

OptimizeRx Corporation (OPRX) is the more profitable company, earning 4.

7% net margin versus 3. 4% for Talkspace, Inc. — meaning it keeps 4. 7% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: OPRX leads at 10. 7% versus 1. 4% for TALK. At the gross margin level — before operating expenses — OPRX leads at 67. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

On forward earnings alone, OptimizeRx Corporation (OPRX) trades at 6.

9x forward P/E versus 38. 3x for Talkspace, Inc. — 31. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for OPRX: 162. 8% to $17. 00.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Talkspace, Inc.

(TALK) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 86)). OptimizeRx Corporation (OPRX) carries a higher beta of 2. 28 — meaning larger drawdowns in market downturns, which matters significantly when you cannot wait years for a recovery. Both have compounded well over 10 years (TALK: -48. 6%, OPRX: +105. 4%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.